OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice
Kana N. Miyata, Chao‐Sheng Lo, Shuiling Zhao, et al.
Clinical Science (2021) Vol. 135, Iss. 7, pp. 943-961
Open Access | Times Cited: 48
Kana N. Miyata, Chao‐Sheng Lo, Shuiling Zhao, et al.
Clinical Science (2021) Vol. 135, Iss. 7, pp. 943-961
Open Access | Times Cited: 48
Showing 26-50 of 48 citing articles:
Effect of dapagliflozin on the initial estimated glomerular filtration rate dip in chronic kidney disease patients without diabetes mellitus
Ryo Shibata, Kensei Taguchi, Yusuke Kaida, et al.
Clinical and Experimental Nephrology (2022) Vol. 27, Iss. 1, pp. 44-53
Open Access | Times Cited: 14
Ryo Shibata, Kensei Taguchi, Yusuke Kaida, et al.
Clinical and Experimental Nephrology (2022) Vol. 27, Iss. 1, pp. 44-53
Open Access | Times Cited: 14
Sodium–glucose cotransporter inhibitors and kidney fibrosis: review of the current evidence and related mechanisms
Barış Afşar, Rengin Elsürer Afşar
Pharmacological Reports (2022) Vol. 75, Iss. 1, pp. 44-68
Closed Access | Times Cited: 13
Barış Afşar, Rengin Elsürer Afşar
Pharmacological Reports (2022) Vol. 75, Iss. 1, pp. 44-68
Closed Access | Times Cited: 13
Dapagliflozin attenuates renal fibrosis by suppressing angiotensin II/TGFβ signaling in diabetic mice
Mingwang Jiang, Zhichen Yang, Lu Lyu, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 2, pp. 108687-108687
Closed Access | Times Cited: 2
Mingwang Jiang, Zhichen Yang, Lu Lyu, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 2, pp. 108687-108687
Closed Access | Times Cited: 2
Lack of renoprotective effects by long-term PCSK9 and SGLT2 inhibition using alirocumab and empagliflozin in obese ZSF1 rats
Sandra Hummelgaard, Henning Hvid, Henrik Birn, et al.
AJP Renal Physiology (2024) Vol. 328, Iss. 1, pp. F48-F67
Closed Access | Times Cited: 2
Sandra Hummelgaard, Henning Hvid, Henrik Birn, et al.
AJP Renal Physiology (2024) Vol. 328, Iss. 1, pp. F48-F67
Closed Access | Times Cited: 2
Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice
Min-Chun Liao, Kana N. Miyata, Shiao‐Ying Chang, et al.
Clinical Science (2022) Vol. 136, Iss. 10, pp. 715-731
Open Access | Times Cited: 11
Min-Chun Liao, Kana N. Miyata, Shiao‐Ying Chang, et al.
Clinical Science (2022) Vol. 136, Iss. 10, pp. 715-731
Open Access | Times Cited: 11
The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1
Yuji Oe, Volker Vallon
Kidney and Dialysis (2022) Vol. 2, Iss. 2, pp. 349-368
Open Access | Times Cited: 11
Yuji Oe, Volker Vallon
Kidney and Dialysis (2022) Vol. 2, Iss. 2, pp. 349-368
Open Access | Times Cited: 11
“Greedy Organs Hypothesis” for sugar and salt in the pathophysiology of non-communicable diseases in relation to sodium-glucose co-transporters in the intestines and the kidney
Hiroshi Itoh, Masami Tanaka
Metabolism Open (2022) Vol. 13, pp. 100169-100169
Open Access | Times Cited: 10
Hiroshi Itoh, Masami Tanaka
Metabolism Open (2022) Vol. 13, pp. 100169-100169
Open Access | Times Cited: 10
Hedgehog interacting protein activates sodium–glucose cotransporter 2 expression and promotes renal tubular epithelial cell senescence in a mouse model of type 1 diabetes
Xin-Ping Zhao, Shiao‐Ying Chang, Yuchao Pang, et al.
Diabetologia (2022) Vol. 66, Iss. 1, pp. 223-240
Open Access | Times Cited: 10
Xin-Ping Zhao, Shiao‐Ying Chang, Yuchao Pang, et al.
Diabetologia (2022) Vol. 66, Iss. 1, pp. 223-240
Open Access | Times Cited: 10
A comprehensive meta-analysis on the association of SGLT2is and GLP-1RAs with vascular diseases, digestive diseases and fractures
Dehua Wang, Yu-Xia Mo, Xiang Tan, et al.
Acta Diabetologica (2024) Vol. 61, Iss. 9, pp. 1097-1105
Closed Access | Times Cited: 1
Dehua Wang, Yu-Xia Mo, Xiang Tan, et al.
Acta Diabetologica (2024) Vol. 61, Iss. 9, pp. 1097-1105
Closed Access | Times Cited: 1
Oxidative Stress in Kidney Injury and Hypertension
William J. Arendshorst, Aleksandr E. Vendrov, Nitin Kumar, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1454-1454
Open Access | Times Cited: 1
William J. Arendshorst, Aleksandr E. Vendrov, Nitin Kumar, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1454-1454
Open Access | Times Cited: 1
Angiotensin II biphasically regulates cell differentiation in human iPSC-derived kidney organoids
Stacy M. Yanofsky, Courtney Dugas, Akemi Katsurada, et al.
AJP Renal Physiology (2021) Vol. 321, Iss. 5, pp. F559-F571
Open Access | Times Cited: 9
Stacy M. Yanofsky, Courtney Dugas, Akemi Katsurada, et al.
AJP Renal Physiology (2021) Vol. 321, Iss. 5, pp. F559-F571
Open Access | Times Cited: 9
Characterization of a murine model of endothelial dysfunction induced by chronic intraperitoneal administration of angiotensin II
Celeste Trejo-Moreno, Enrique Jiménez‐Ferrer, Gabriela Castro-Martínez, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Celeste Trejo-Moreno, Enrique Jiménez‐Ferrer, Gabriela Castro-Martínez, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Combining renin-angiotensin system blockade and sodium-glucose cotransporter-2 inhibition in experimental diabetes results in synergistic beneficial effects
Edwyn O. Cruz‐López, Dien Ye, Daniël G. Stolk, et al.
Journal of Hypertension (2023) Vol. 42, Iss. 5, pp. 883-892
Closed Access | Times Cited: 3
Edwyn O. Cruz‐López, Dien Ye, Daniël G. Stolk, et al.
Journal of Hypertension (2023) Vol. 42, Iss. 5, pp. 883-892
Closed Access | Times Cited: 3
Renoprotection with sodium‐glucose cotransporter‐2 inhibitors in children: Knowns and unknowns
Buchun Jiang, Zhiwen Cheng, Fei Liu, et al.
Nephrology (2021) Vol. 27, Iss. 2, pp. 126-132
Open Access | Times Cited: 7
Buchun Jiang, Zhiwen Cheng, Fei Liu, et al.
Nephrology (2021) Vol. 27, Iss. 2, pp. 126-132
Open Access | Times Cited: 7
Renal Protection and Safety of Sodium-glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease
Tian‐Biao Zhou, Kaijin Yao, Yina Xie, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 21, pp. 1659-1670
Closed Access | Times Cited: 2
Tian‐Biao Zhou, Kaijin Yao, Yina Xie, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 21, pp. 1659-1670
Closed Access | Times Cited: 2
Vasoactive Substances as Mediators of Renal Injury
Paulo S. Caceres, Noreen F. Rossi
Elsevier eBooks (2024)
Closed Access
Paulo S. Caceres, Noreen F. Rossi
Elsevier eBooks (2024)
Closed Access
Intracellular Angiotensin II Stimulation of Sodium Transporter Expression in Proximal Tubule Cells via AT1 (AT1a) Receptor-Mediated, MAP Kinases ERK1/2- and NF-кB-Dependent Signaling Pathways
Xiaochun Li, Jia L. Zhuo
Cells (2023) Vol. 12, Iss. 11, pp. 1492-1492
Open Access | Times Cited: 1
Xiaochun Li, Jia L. Zhuo
Cells (2023) Vol. 12, Iss. 11, pp. 1492-1492
Open Access | Times Cited: 1
Canagliflozin and irbesartan ameliorate renal fibrosis via the TGF-β1/Smad signaling pathway in Dahl salt-sensitive rats
Jianlong Zhai, Zhongli Wang, Tingting Zhang, et al.
Journal of International Medical Research (2023) Vol. 51, Iss. 10
Open Access | Times Cited: 1
Jianlong Zhai, Zhongli Wang, Tingting Zhang, et al.
Journal of International Medical Research (2023) Vol. 51, Iss. 10
Open Access | Times Cited: 1
Sex-dependent effects of Canagliflozin on kidney protection in mice with combined hypertension-type 1 diabetes
Mayra Trentin‐Sonoda, Véronique Cheff, Alex Gutsol, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0295284-e0295284
Open Access | Times Cited: 1
Mayra Trentin‐Sonoda, Véronique Cheff, Alex Gutsol, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0295284-e0295284
Open Access | Times Cited: 1
SGLT2i relieve proteinuria in diabetic nephropathy patients potentially by inhibiting renal oxidative stress rather than through AGEs pathway
Xiaochun Zeng, Yuan Tian, Xianming Liang, et al.
Research Square (Research Square) (2023)
Open Access
Xiaochun Zeng, Yuan Tian, Xianming Liang, et al.
Research Square (Research Square) (2023)
Open Access
Effects of Two Soluble ACE2-Fc Variants on Blood Pressure and Albuminuria in Hypertensive Mice: Research Letter
Mayra Trentin‐Sonoda, Joseph Zimpelmann, Karishma Tailor, et al.
Canadian Journal of Kidney Health and Disease (2023) Vol. 10
Open Access
Mayra Trentin‐Sonoda, Joseph Zimpelmann, Karishma Tailor, et al.
Canadian Journal of Kidney Health and Disease (2023) Vol. 10
Open Access
Paradoxical Dapagliflozin Effect on Proteinuria in a Female Patient with Classic Fabry Disease First Literatura Report
Sebastián Jaurretche, Facundo Daminato
Austin Journal of Nephrology and Hypertension (2023) Vol. 10, Iss. 1
Open Access
Sebastián Jaurretche, Facundo Daminato
Austin Journal of Nephrology and Hypertension (2023) Vol. 10, Iss. 1
Open Access
Renoprotection by Dapagliflozin in a Non-Diabetic Model of Cardiorenal Syndrome
Konrad Urbanek, Donato Cappetta, Gabriella Bellocchio, et al.
SSRN Electronic Journal (2022)
Closed Access
Konrad Urbanek, Donato Cappetta, Gabriella Bellocchio, et al.
SSRN Electronic Journal (2022)
Closed Access
Effects of canagliflozin and irbesartan on renal fibrosis in Dahl salt-sensitive rats
Jianlong Zhai, Zhongli Wang, Tingting Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Jianlong Zhai, Zhongli Wang, Tingting Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
